首页|基于长链脂肪酸及相关代谢酶治疗非酒精性脂肪性肝病的研究进展

基于长链脂肪酸及相关代谢酶治疗非酒精性脂肪性肝病的研究进展

扫码查看
长链脂肪酸,即碳原子数大于12,小于等于20的脂肪酸,是膳食中含量最高的脂肪酸类别。长链脂肪酸参与维持细胞膜的正常结构和基本功能,在机体能量代谢、糖脂代谢及免疫炎症反应中都发挥着重要作用。而肝细胞中,长链脂肪酸超载可从诱导炎症、氧化应激、纤维化、自噬、细胞凋亡等多种途径诱导肝损伤。本文综述了基于长链脂肪酸及相关代谢酶治疗非酒精性脂肪性的研究进展,为非酒精性脂肪性肝病的治疗提供新的思路和方法。
Research progress in the treatment of non-alcoholic fatty liver disease based on the long chain fatty acids and related metabolic enzymes
Long-chain fatty acids(LCFA)are defined as fatty acids with 12~20 carbons.LCFA are the most abundant type of fatty acids in diet.LCFA are involved in maintaining the normal structure and basic function of cell membranes,which play an important role in energy metabolism of the organism,glucose and lipid metabolism,and inflammatory response.In hepatocytes,an overload of LCFA can induce liver injury in various ways such as inflammation,oxidative stress,fibrosis,autophagy,and apoptosis.This article reviewd the research progress of treating non-alcoholic fatty disease based on long chain fatty acids and related metabolic enzymes,providing new ideas and strategies for the treatment of non-alcoholic fatty liver disease.

Non-alcoholic fatty liver diseaseLong chain fatty acidFatty acid metabolism

张荣觅、陆茜、金铭、黄小菲、俞沁玮、江振洲

展开 >

中国药科大学,多靶标天然药物全国重点实验室,新药筛选与药效评价中心,江苏省药效研究与评价服务中心,江苏南京 210009

中国药科大学,药物质量与安全预警教育部重点实验室,江苏南京 210009

非酒精性脂肪性肝病 长链脂肪酸 脂肪酸代谢

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(12)